Osteoporosis :: International study strengthens case for daily calcium pill
A landmark study by University of Western Sydney researchers has found people over 50 who take calcium supplements suffer fewer fractures and enjoy a better quality of life.
A landmark study by University of Western Sydney researchers has found people over 50 who take calcium supplements suffer fewer fractures and enjoy a better quality of life.
Vioxx and related pain medications were taken off the market in 2004 because they caused dangerous heart problems in some people. A group of scientists, led by Timothy Hla at the University of Connecticut, may now have figured out how these drugs trigger these life-threatening side-effects.
University of Minnesota researchers have discovered that treating people who have early cardiovascular abnormalities, but show no symptoms of cardiovascular disease, can slow progression and even reverse damage to the heart and blood vessels.
New findings that one in 20 North Carolina men who have sex with men (MSM) reported using crystal methamphetamine during the previous month suggests increased risk for spreading HIV and other sexually transmitted diseases, according to researchers from Wake Forest University School of Medicine and colleagues.
Geron Corporation (Nasdaq: GERN) today reported its scientists and collaborators have demonstrated that human embryonic stem cell (hESC)-derived cardiomyocytes improve heart function when transplanted after myocardial infarction.
Obesity has long been thought to be a major factor in couples’ inability to conceive, but a University of Adelaide researcher has discovered scientific evidence that obesity affects women’s eggs.
Though the overall incidence of head and neck cancers has fallen in the United States, the rate of oropharyngeal (chiefly, tonsil and base of tongue) cancers is stagnant and appears to be rising is certain populations and these trends are likely due to oncogenic human papillomavirus (HPV) infection.
On 23 August 2007, Dr Howard Zucker, Head of the WHO cluster Health Technology and Pharmaceuticals and Representative of the Director-General on Intellectual Property, Innovation and Public Health of the World Health Organization (WHO), was visiting the Paul-Ehrlich-Institut (PEI) at Langen near Frankfurt am Main, Germany.
Avastin (bevacizumab), Roche’s innovative anti-cancer drug, was approved today in Europe for the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC), in combination with platinum-based chemotherapy.
When human heart muscle cells derived from embryonic stem cells are implanted into a rat after a heart attack, they can help rebuild the animal’s heart muscle and improve function of the organ, scientists report in the September issue of Nature Biotechnology.